OCTOBER 20, 2021 - Resilience is the ability of an individual to recover or maintain relatively stable psychological and physical functioning when confronted with stressful life events and adversities. In a study published in Psycho-Oncology that included 193 patients with breast cancer who were receiving chemotherapy before undergoing surgery, investigators assessed resilience through questionnaires.
Those with resilience were less likely to experience depressive symptoms during chemotherapy, and in turn, experience better health-related quality of life after chemotherapy.
The results suggest that patients with breast cancer who have low resilience may be at risk for developing depression during chemotherapy.
“Patients receiving chemotherapy for breast cancer, especially those with low resilience, should be screened and treated for depression to maintain their health-related quality of life,” said lead author Sungwon Lee, MD, of Seoul National University College of Medicine.
Full Citation: “Psychiatric symptoms mediate the effect of resilience on health-related quality of life in patients with breast cancer: Longitudinal examination.” Sungwon Lee, Saim Jung, Sanghyup Jung, Jung Yoon Moon, Gyu Han Oh, Chan-Woo Yeom, Kyung-Lak Son, Kwang-Min Lee, Won-Hyoung Kim, Dooyoung Jung, Tae-Yong Kim, Seock-Ah Im, Kyung-Hun Lee, Eun-Jung Shim, Bong-Jin Hahm. Psychooncology; Published Online: October 20, 2021 (DOI: 10.1002/pon.5829).
URL Upon Publication: https://doi.org/10.1002/pon.5829
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd., reproduced with permission.
- Copyright: © Saudi Medical Journal
This is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.